The dubious distinction of worst hedge fund performance in the 2nd quarter -- based on equal weightings of 13F positions -- goes to Tiger Pacific Capital LP. An equal weighting of the fund’s 14 positions returned -21.69% in the quarter, according to WhaleWisdom.com
U.S. Hedge Funds are buying cannabis stocks. Despite regulatory issues and limited investment choices, the "smart money" is increasingly eager to gain exposure to the booming marijuana sector.
But you won't see Warren Buffett and Charlie Munger jumping on the pot stock...
Cloning Carl Icahn is a good idea.
Now I'm of course not talking about a laboratory experiment whereby we create an army of little corporate activists that will grow into so many billionaires.
Rather, I'm referring to following the renowned...
After regular market hours on Wednesday, the Head of Alternative Investments for B. Riley Capital filed Form 4s disclosing personal purchases of Health Insurance Innovations (HIIQ) shares in addition to purchases for the fund he manages.
Also after market hours, Paul Gabos, a HIIQ...
In a 13D filed on Jan. 21 targeting Garrison Capital (GARS), corporate activist Joseph Stilwell notes that he has taken an "activist position" in 68 publicly-traded companies since 2000.
In his most recent 13D, Stilwell Value, LLC disclosed a 5% stake in Garrison, a...
On December 27, 2018, Cannell Capital LLC — a hedge fund based in Alta, Wyoming – disclosed sending three separate letters to three company managements, notifying them of Cannell’s activist intentions. Buying the stocks targeted by Cannell on that date would have produced an average gain of 32.40% over the 25 trading days since.
The best performing hedge funds are often ones you haven't heard of. You're not doubt familiar with Berkshire Hathaway and Bridgewater Associates. But you probably don't know Casdin Capital or King Street Management.
While investors fawned over Bridgewater's 14.6% gain...
Ark Investment Management Founder, CEO and Portfolio Manager Catherine Wood invests in what she calls "Disruptive Innovation." Wood has been successful with this approach, to say the least. Cloning Ark Investments' 13F portfolio since Q1 of 2017 would have resulted in a 39.74% annualized return. That's nearly...
Michael Burry's Scion Management averaged down on the fund's position in Tailored Brands (TLRD), buying 402,900 shares of the distressed retailer in the days leading up to March 16. Scion now owns 7.2% of the company. TLRD closed at $1.29 on March 20, down 69% year-to date....
Perceptive Advisors' Neptune Wellness Solutions (NEPT) position increased by 50% during the 3rd quarter of 2019, to 4.5 million shares. The stake represents 14.53% of the Cannabis extraction company's outstanding shares. NEPT was Perceptive Advisors' #20 position at Q3 close.
The increase in Perceptive'...